Wasatch Advisors LP Sells 62,195 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS)

Wasatch Advisors LP trimmed its stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 11.6% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 473,101 shares of the company’s stock after selling 62,195 shares during the quarter. Wasatch Advisors LP’s holdings in OrthoPediatrics were worth $12,826,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. BNP Paribas Financial Markets lifted its position in shares of OrthoPediatrics by 125.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock worth $94,000 after buying an additional 1,929 shares during the last quarter. Quantbot Technologies LP lifted its position in shares of OrthoPediatrics by 42.2% during the 3rd quarter. Quantbot Technologies LP now owns 5,773 shares of the company’s stock worth $157,000 after buying an additional 1,712 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of OrthoPediatrics by 2.1% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 132,434 shares of the company’s stock worth $3,590,000 after buying an additional 2,661 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of OrthoPediatrics during the 3rd quarter worth $295,000. Finally, Quest Partners LLC lifted its position in shares of OrthoPediatrics by 924.4% during the 3rd quarter. Quest Partners LLC now owns 11,986 shares of the company’s stock worth $325,000 after buying an additional 10,816 shares during the last quarter. 69.05% of the stock is currently owned by institutional investors.

OrthoPediatrics Stock Performance

Shares of KIDS opened at $25.98 on Friday. OrthoPediatrics Corp. has a 12-month low of $22.41 and a 12-month high of $36.23. The business has a 50-day simple moving average of $26.04 and a two-hundred day simple moving average of $29.10. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19.

Analyst Upgrades and Downgrades

KIDS has been the subject of several recent analyst reports. JMP Securities restated a “market outperform” rating and set a $50.00 price objective on shares of OrthoPediatrics in a research report on Friday, September 13th. Truist Financial dropped their price objective on OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating for the company in a research report on Monday, October 14th. Finally, Needham & Company LLC restated a “buy” rating and set a $42.00 price objective on shares of OrthoPediatrics in a research report on Friday, November 8th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.